| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023700865 |
| P356 | DOI | 10.1007/S00213-010-1789-8 |
| P932 | PMC publication ID | 2834964 |
| P698 | PubMed publication ID | 20179908 |
| P5875 | ResearchGate publication ID | 41548959 |
| P2093 | author name string | Goldberg SR | |
| Solinas M | |||
| Tanda G | |||
| Wertheim CE | |||
| P2860 | cites work | The endocannabinoid system as a target for the treatment of cannabis dependence | Q24648135 |
| Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis | Q28268078 | ||
| Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
| Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data | Q30807024 | ||
| Cannabis: discrimination of "internal bliss"? | Q33748898 | ||
| Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans | Q33886277 | ||
| Dopamine receptors: from structure to behavior | Q34070870 | ||
| Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. | Q34101143 | ||
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse | Q34631254 | ||
| The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders | Q35586641 | ||
| Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system | Q35908727 | ||
| Endocannabinoid system involvement in brain reward processes related to drug abuse | Q36357182 | ||
| The endocannabinoid system in brain reward processes | Q36741861 | ||
| Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog | Q37055254 | ||
| Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats | Q37146387 | ||
| Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates | Q37239653 | ||
| Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol | Q37266063 | ||
| Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study | Q41130886 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior | Q42464704 | ||
| Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons | Q42484453 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| A cannabinoid mechanism in relapse to cocaine seeking. | Q43759232 | ||
| Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. | Q44048463 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
| Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats | Q44347637 | ||
| A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission | Q44853701 | ||
| Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol. | Q44951522 | ||
| Lack of CB1 cannabinoid receptor impairs cocaine self-administration. | Q45292739 | ||
| Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide | Q48247701 | ||
| Cannabinoid transmission and reward-related events | Q48285165 | ||
| The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport | Q48315882 | ||
| Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids | Q48383234 | ||
| Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats | Q48485540 | ||
| Two brain sites for cannabinoid reward. | Q48556363 | ||
| Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats | Q48608961 | ||
| The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats. | Q51550730 | ||
| Discriminative Stimulus Properties of Δ9-Tetrahydrocannabinol: Mechanistic Studies | Q52292952 | ||
| Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum | Q64789945 | ||
| The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive | Q73180328 | ||
| P433 | issue | 2 | |
| P921 | main subject | dopamine | Q170304 |
| tetrahydrocannabinol | Q190067 | ||
| anandamide | Q410228 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 191-202 | |
| P577 | publication date | 2010-02-24 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamide | |
| P478 | volume | 209 |
| Q90524726 | Brain activity of anandamide: a rewarding bliss? |
| Q93258985 | Cannabinoid-induced lower lip retraction in rats |
| Q37554546 | Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice |
| Q86825974 | Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex |
| Q90654820 | Dopamine and addiction: what have we learned from 40 years of research |
| Q44467061 | Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy? |
| Q35532072 | Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors |
| Q35685476 | Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride |
| Q34257459 | Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys |
| Q33727978 | Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. |
| Q35166968 | Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum |
| Q37356740 | Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. |
Search more.